We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ASML
ASML
$675B
| $173M | 2.05% |
238,446
+127,213
| +114% | +$86.5M |
|
|
ATVI
2
DELISTED
Activision Blizzard
ATVI
| $144M | 1.71% |
1,707,676
+1,330,711
| +353% | +$108M |
|
|
3
Johnson & Johnson
JNJ
$634B
| $143M | 1.7% |
864,407
+762,872
| +751% | +$123M |
|
4
Eli Lilly
LLY
$1.07T
| $138M | 1.64% |
294,853
+187,624
| +175% | +$78.7M |
|
5
Amphenol
APH
$188B
| $134M | 1.59% |
3,155,730
-254,522
| -7% | -$9.89M |
|
|
6
Microsoft
MSFT
$2.84T
| $131M | 1.56% |
385,544
+322,197
| +509% | +$101M |
|
|
7
Cencora
COR
$60.3B
| $131M | 1.55% |
679,012
+611,339
| +903% | +$106M |
|
|
HES
8
DELISTED
Hess
HES
| $114M | 1.35% |
+837,083
| New | +$115M |
|
9
Neurocrine Biosciences
NBIX
$17.7B
| $109M | 1.29% |
1,152,189
+753,495
| +189% | +$73.6M |
|
10
Merck
MRK
$324B
| $102M | 1.21% |
882,500
+180,697
| +26% | +$20.5M |
|
11
RTX Corp
RTX
$287B
| $101M | 1.2% |
1,034,015
+58,565
| +6% | +$5.73M |
|
12
Revolution Medicines
RVMD
$40.2B
| $101M | 1.19% |
3,761,375
+338,403
| +10% | +$8.3M |
|
13
Cooper Companies
COO
$13.7B
| $97.8M | 1.16% |
1,019,864
+51,676
| +5% | +$4.85M |
|
14
Meta Platforms (Facebook)
META
$1.51T
| $96.1M | 1.14% |
334,826
+10,792
| +3% | +$2.66M |
|
15
HP
HPQ
$23.5B
| $91.2M | 1.08% |
+2,971,304
| New | +$89.2M |
|
|
MRO
16
DELISTED
Marathon Oil Corporation
MRO
| $89.6M | 1.06% |
+3,891,891
| New | +$91.7M |
|
17
L3Harris
LHX
$55.9B
| $88.7M | 1.05% |
453,333
+47,207
| +12% | +$9.03M |
|
18
Ciena
CIEN
$55.3B
| $85.4M | 1.01% |
2,009,887
+1,811,301
| +912% | +$82.5M |
|
19
Huntington Ingalls Industries
HII
$11.3B
| $85M | 1.01% |
373,442
-75,671
| -17% | -$15.7M |
|
20
Applied Materials
AMAT
$426B
| $82.6M | 0.98% |
+571,167
| New | +$71.5M |
|
21
Johnson Controls International
JCI
$87.5B
| $81.6M | 0.97% |
1,197,465
-177,245
| -13% | -$10.9M |
|
22
Amgen
AMGN
$203B
| $72.8M | 0.86% |
327,937
+250,050
| +321% | +$58M |
|
|
PR
23
Permian Resources
PR
$17.9B
| $70M | 0.83% |
+6,383,594
| New | +$65.3M |
|
24
Pentair
PNR
$10.2B
| $65.8M | 0.78% |
1,018,848
-280,613
| -22% | -$16.2M |
|
25
McDonald's
MCD
$188B
| $65.1M | 0.77% |
218,247
+110,379
| +102% | +$32.1M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.